HNX:MED Revenue

In the year 2025, Mediplantex National Pharmaceutical JSC had annual revenue of 367.08B VND, down -17.16%. Mediplantex National Pharmaceutical JSC had revenue of 117.61B in the quarter ending December 31, 2025, with 11.04% growth.

Revenue

367.08B

Revenue Growth

-17.16%

P/S Ratio

0.69

Revenue / Employee

1.12B

Employees

328

Market Cap

253.16B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	367.08B	-76.05B	-17.16%
Dec 31, 2024	443.14B	40.39B	10.03%
Jan 1, 2024	402.74B	1.69B	0.42%
Dec 31, 2022	401.05B	57.10B	16.60%
Dec 31, 2021	343.95B	-177.44B	-34.03%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Vimedimex Medi-Pharma JSC	1,172.99B
Ben Tre Pharmaceutical JSC	860.40B
Phong Phu Pharmaceutical JSC	139.83B
Lamdong Pharmaceutical JSC	243.91B
SPM Corporation	253.96B
Cai Lay Veterinary Pharmaceutical JSC	148.87B
Vidipha Central Pharmaceutical JSC	950.89B
Pharmedic Pharmaceutical Medicinal JSC	546.57B

Revenue Rankings